| NDC Code | 70934-125-96 |
|---|
| Package Description | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-125-96) |
|---|
| Product NDC | 70934-125 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Bupropion Hydrochloride |
|---|
| Non-Proprietary Name | Bupropion Hydrochloride |
|---|
| Dosage Form | TABLET, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20220706 |
|---|
| End Marketing Date | 20240430 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA090693 |
|---|
| Manufacturer | Denton Pharma, Inc. DBA Northwind Pharmaceuticals |
|---|
| Substance Name | BUPROPION HYDROCHLORIDE |
|---|
| Strength | 150 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA] |
|---|